Abstract:Recurrent pregnancy loss (RPL) is a complex early pregnancy complication affecting 1-2% of couples and is often linked to immune dysfunction. Aberrations in T and B cell subpopulations, as well as natural killer (NK) cell activity, are particularly influential, with studies showing that abnormal NK cell activation and imbalances in T and B cell subtypes contribute to immune-mediated miscarriage risk. Successful pregnancy requires a tightly regulated balance between pro-inflammatory and anti-inflammatory immune responses. In the early stages, inflammation supports processes such as trophoblast invasion and spiral artery remodeling, but this must be tempered to prevent immune rejection of the fetus. In this review, we explore the underlying immune mechanisms of RPL, focusing on how dysregulated T, B, and NK cell function disrupts maternal tolerance. Specifically, we discuss the essential role of uterine NK cells in the early stages of vascular remodeling in the decidua and regulate the depth of invasion by extravillous trophoblasts. Furthermore, we focus on the delicate Treg dynamics that enable the maintenance of optimal immune homeostasis, where the balance, and not only the quantity of Tregs, is crucial for fostering maternal-fetal tolerance. Other T cell subpopulations, such as Th1, Th2, and Th17 cells, also contribute to immune imbalance, with Th1 and Th17 cells promoting inflammation and potentially harming fetal tolerance, while Th2 cells support immune tolerance. Finally, we show how changes in B cell subpopulations and their functions have been associated with adverse pregnancy outcomes. We further discuss current therapeutic strategies aimed at correcting these immune imbalances, including intravenous immunoglobulin (IVIg), glucocorticoids, and TNF-α inhibitors, examining their efficacy, challenges, and potential side effects. By highlighting both the therapeutic benefits and limitations of these interventions, we aim to offer a balanced perspective on clinical applications for women facing immune-related causes of RPL.

Immune Function and Recurrent Pregnancy Loss

Immune Checkpoints in Recurrent Pregnancy Loss: New Insights into a Detrimental and Elusive Disorder

Integrative Analysis of Circulating Micrornas and the Placental Transcriptome in Recurrent Pregnancy Loss

Alloimmune Causes of Recurrent Pregnancy Loss: Cellular Mechanisms and Overview of Therapeutic Approaches

Recurrent Pregnancy Loss: Immunological aetiologies and associations with mental health

The Update Immune-Regulatory Role of Pro- and Anti-Inflammatory Cytokines in Recurrent Pregnancy Losses

Unexplained Recurrent Pregnancy Loss: Clinical Application of Immunophenotyping

Immunological Modes of Pregnancy Loss: Inflammation, Immune Effectors, and Stress

Maternal–Fetal Compatibility in Recurrent Pregnancy Loss

The peripheral and decidual immune cell profiles in women with recurrent pregnancy loss

Immunological Indicators of Recurrent Pregnancy Loss: A Mendelian Randomization Study

The Association of Gut Microbiome with Recurrent Pregnancy Loss: A Comprehensive Review

Systemic Characterization of Novel Immune Cell Phenotypes in Recurrent Pregnancy Loss

Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?

Immunomodulation in Recurrent Miscarriage

Microbiota and Recurrent Pregnancy Loss (RPL); More than a Simple Connection

Bibliometric analysis of the global trends in immune‐related recurrent pregnancy loss research over the last two decades

The Immune Atlas of Human Deciduas With Unexplained Recurrent Pregnancy Loss

Autoimmune Condition Diagnosis Following Recurrent Pregnancy Loss

Understanding recurrent pregnancy loss: recent advances on its etiology, clinical diagnosis, and management

Single-cell profiling of the human decidual immune microenvironment in patients with recurrent pregnancy loss